Plain-English translation of NCT07450859 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new drug called nuzefatide pevedotin to see if it can help treat pancreatic cancer that has spread to other parts of the body and continued to grow despite previous treatment. The medication works by targeting a specific protein often found on pancreatic cancer cells and delivering a powerful anti-cancer agent directly to those cells. Researchers want to learn whether this treatment is effective and safe for patients like you.
Pancreatic cancer is very difficult to treat, especially when it has spread or stopped responding to standard chemotherapy. This medication represents a new approach that may help patients whose cancer has already progressed through one line of prior therapy.
You likely qualify if…
You likely don't qualify if…
You would receive nuzefatide pevedotin as the sole treatment in this trial at a medical center participating in the study. The trial involves visits where researchers will monitor how well the medication is working and check for any side effects through physical exams, blood tests, and scans. A sample of your tumor tissue will also be analyzed to understand how the medication works best for you.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
United States